Âé¶¹´«Ã½

Our Âé¶¹´«Ã½ on Âé¶¹´«Ã½

Eight Early-Career Scientists Will Attend the AACR Annual Meeting with Ludwig Support

Ludwig Cancer Research is proud to support eight early-career scientists presenting their research at the conference this year through the AACR Scholar-in-Training Awards (SITA) program, contributing to the cost of their travel and attendance at the...
25-Apr-2025 7:40 PM EDT Add to Favorites

Ludwig Cancer Research scientists to present at AACR Annual Meeting

Ludwig Cancer Research released today the full scope of research to be presented by Ludwig-affiliated scientists at the American Association for Cancer Research (AACR) Annual Meeting 2025, which will be held online and in person in Chicago, from...
25-Apr-2025 6:25 PM EDT Add to Favorites

Âé¶¹´«Ã½: 67ffd15e7b629_Screenshot2025-04-16110928.png

Reprogramming Cancer Cells to Treat an Aggressive Type of Leukemia

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.
16-Apr-2025 5:15 PM EDT Add to Favorites

Âé¶¹´«Ã½: 67e17b02afb44_Screenshot2025-03-24112003.png

Why Brain Metastases of Breast Cancer Resist a Promising Candidate Therapy

A Ludwig Cancer Research study has identified a key barrier to the efficacy of a promising combination of radiotherapy and immunotherapy for the treatment of brain metastases arising from breast cancer—and in doing so uncovered approaches to...
24-Mar-2025 6:10 PM EDT Add to Favorites

Âé¶¹´«Ã½: 67d0683f402ad_Screenshot2025-03-11124331.png

Ludwig Harvard’s Bradley Bernstein elected Fellow of the AACR Academy

Ludwig Cancer Research extends its congratulations to Ludwig Harvard’s Bradley Bernstein on his election as Fellow of the Academy of the American Association for Cancer Research.
11-Mar-2025 8:00 PM EDT Add to Favorites

Âé¶¹´«Ã½: 67d03c5facfa2_Screenshot2025-03-11093619.png

Ludwig Lausanne’s Douglas Hanahan Honored for His Contributions to Cancer Research

Ludwig Cancer Research congratulates Douglas Hanahan, Ludwig Distinguished Scholar at the Lausanne Branch of the Ludwig Institute for Cancer Research, on his selection as recipient of the Pezcoller Foundation-AACR International Award for...
11-Mar-2025 9:40 AM EDT Add to Favorites

Âé¶¹´«Ã½: 6716af948d313_Screenshot2024-10-21153953.png

A Remote-Controlled Car for Cancer Immunotherapy

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be switched on to varying degrees of intensity and then switched off on demand with existing drugs.
21-Oct-2024 3:45 PM EDT Add to Favorites

Âé¶¹´«Ã½: 6716712ea2ea2_Screenshot2024-05-07111244.png

Ludwig Lausanne Director George Coukos elected to the National Academy of Medicine

Ludwig Cancer Research congratulates Ludwig Lausanne Director George Coukos on his election to the U.S. National Academy of Medicine (NAM). Among the highest honors issued to clinicians and scientists, membership in the Academy recognizes...
21-Oct-2024 11:15 AM EDT Add to Favorites


See All News

Our Experts on News

Our experts are coming soon...

About

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer discoveries for more than 40 years. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Experts

Twitter

Facebook

close
0.27509